Aarhus University logo
The Nordic EMBL Partnership has opened its annual call for outstanding students seeking PhDs in molecular medicine.
The “Where Are They Now? Nordic EMBL Partnership Alumni Careers” profile series introduces readers to alumni of the Nordic EMBL Partnership and the careers that they have embarked on. To kick-off the series, we highlight the recent FIMM Alumni Visit in December 2021 and peek into careers in industry.
The new profile series “Technologies Advancing Molecular Medicine” highlights the people and activities in the technologies and core facilities in the Nordic EMBL Partnership for Molecular Medicine. To kick-off the new series, we showcase the Building Bridges 2021 symposium: Technologies advancing molecular medicine – focus on Nordic infrastructures, held in December 2021.
The “Behind the Science'' profile series takes an in-depth look at a scientist or group within the Nordic EMBL Partnership. In this article, we meet DANDRITE group leader, Mark Denham, and learn about the advances he and his group have made in Parkinson’s disease research.
Analysing molecular characteristics and their variation during lifestyle changes, by combining digital tools, classical laboratory tests and new biomolecular measurements, could enable individualised prevention of disease. This is according to a new study from Karolinska Institutet in Sweden and the University of Helsinki in Finland published in the journal Cell Systems. The researchers show what a proactive healthcare model could comprise and how it could help in maintaining good health.
Meet Young DANDRITE, or YoDA, the association of early-career researchers uniting the scientists at DANDRITE
A group of Nordic researchers has discovered a novel immune deficiency disease affecting the regulation of the immune system. A mutation in the IKZF2 gene was identified in a Finnish family with recurrent infections and signs of immune overactivation. The results provide a basis for a deeper understanding of the molecular mechanisms behind activation and maturation of T cells and will aid the diagnosis of rare inborn errors of immunity.
Join us as we shine the spotlight on technologies used to improve our understanding of health and disease and to bridge science across borders.
All EMBL staff, alumni, their colleagues and networks are invited to EMBL in Denmark 2021: Enzymes of the future at the Technical University of…
Join us for the 23rd Anniversary of the annual EMBL PhD Symposium. Since its conception in 1999, the EMBL PhD Symposium has evolved into a highly…
A group of Nordic researchers has discovered a novel immune deficiency disease affecting the regulation of the immune system. A mutation in the IKZF2 gene was identified in a Finnish family with recurrent infections and signs of immune overactivation. The results provide a basis for a deeper understanding of the molecular mechanisms behind activation and maturation of T cells and will aid the diagnosis of rare inborn errors of immunity. doi: 10.1126/sciimmunol.abe3454
